Oragenics Inc. Common Stock (OGEN)
Stock · AMEX · Health Care
$0.43as of 10/16/2026
Price chart
Active signals
OGEN Signal Track Record
How signals performed across all stocks →What OGEN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 27 | -1.8% | 37% | September 28, 2026 |
| Volume SpikeActive now | 22 | -13.2% | 18% | September 28, 2026 |
| Bollinger Band Breakout | 16 | -11.6% | 31% | February 26, 2026 |
| 200-Day Moving Average TouchActive now | 3 | +36.4% | 67% | February 20, 2024 |
| Any 20-session window (baseline) | -8.2% | 31% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About OGEN
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 3
- Website
- www.oragenics.com/
Fundamentals
- 1-day range
- $0.43$0.4538
- Market cap
- $2.45M
- P/E (trailing)
- 0.56
- P/E (forward)
- -0.04
- EPS (trailing)
- $-5.61
- Dividend yield
- —
- Beta
- 1.28
- Avg. volume
- 29.5K
- Dividend pay date
- January 22, 2018
How Oragenics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2023 annual results
Source: 10-K filed Mar 29, 2024 · via SEC EDGAR / Finnhub
Oragenics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- OGENOragenics Inc. Common Stock$0.43▼ 2.27%Market cap $2.45MP/E 0.56$0.43$1.45
- DCOYDecoy Therapeutics Inc. Common Stock$1.17▼ 4.88%Market cap $2.40MP/E —$2.01$55.92
- CDTCDT Equity Inc. Common Stock$0.235▲ 12.44%Market cap $2.54MP/E —$0.1813$28,125
- PPBTPurple Biotech Ltd. American Depositary Shares$1.14▼ 7.32%Market cap $2.29MP/E —$1$2.2
- ARTLArtelo Biosciences Inc. Common Stock$2.7▼ 1.46%Market cap $2.62MP/E —$2.92$179.19
- GNPXGenprex Inc. Common Stock$2.11▼ 7.86%Market cap $2.24MP/E —$2.53$1,210
- AZTRAzitra Inc Common Stock$0.072▲ 0.00%Market cap $2.18MP/E 6.22$0.0518$1.09
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| OGEN Oragenics Inc. Common Stock | $2.45M | 0.56 | $0.43 | ▼ 2.27% | $0.43$1.45 |
| DCOY Decoy Therapeutics Inc. Common Stock | $2.40M | — | $1.17 | ▼ 4.88% | $2.01$55.92 |
| CDT CDT Equity Inc. Common Stock | $2.54M | — | $0.235 | ▲ 12.44% | $0.1813$28,125 |
| PPBT Purple Biotech Ltd. American Depositary Shares | $2.29M | — | $1.14 | ▼ 7.32% | $1$2.2 |
| ARTL Artelo Biosciences Inc. Common Stock | $2.62M | — | $2.7 | ▼ 1.46% | $2.92$179.19 |
| GNPX Genprex Inc. Common Stock | $2.24M | — | $2.11 | ▼ 7.86% | $2.53$1,210 |
| AZTR Azitra Inc Common Stock | $2.18M | 6.22 | $0.072 | ▲ 0.00% | $0.0518$1.09 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 10/9/2026
- Oragenics Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation ForumYahoo · 9/16/2026
Insider Activity
Insider Actions →- Spencer John · July 1, 2026 · Grant55.9K
Institutional Ownership
March 31, 2026
- Total shares held
- 190.4K
- Total value held
- $86.4K
- Institutional holders
- 21
- Unknown65.1K
- Unknown55.0K
- Unknown20.3K
- Unknown18.7K
- Unknown17.6K
- Unknown5.2K
- Unknown4.5K
- Unknown2.0K
- Unknown1.0K
- Unknown703
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Oragenics (OGEN) noted in after‑market health‑care stock activity
OGEN was listed among twelve health‑care companies that showed price movement in Friday’s after‑market session, according to Benzinga. The mention highlights recent trading activity outside regular hours, which can influence short‑term sentiment. The stock is currently near its $0.58 support level and its RSI of about 40 reflects modest momentum.
Oragenics (OGEN) noted in after‑market health‑care stock activity. OGEN was listed among twelve health‑care companies that showed price movement in Friday’s after‑market session, according to Benzinga. The mention highlights recent trading activity outside regular hours, which can influence short‑term sentiment. The stock is currently near its $0.58 support level and its RSI of about 40 reflects modest momentum.